Healthtech startup Neodocs raises pre-seed from Y Combinator, 9Unicorns and Titan Capital

The AI-based platform essentially transforms users’ smartphones into a mini lab – one can simply take the test, click a picture, and receive the results instantly on their phone.

Vaishnavi Desai
New Update
Healthtech funding

9Unicorns, an idea-phase accelerator VC fund, has led a pre-seed investment round in AI-enabled healthtech platform NeoDocs, along with Y Combinator and Titan Capital. NeoDocs will be utilizing the proceeds from the fund raise to strengthen its core technology framework, increase presence and expand its team.


Founded by IIT Bombay alumni Nikunj Malpani (ex-Bain & Co.), Anurag Meena (3X Med-tech entrepreneur) and Pratik Lodha (ex-Pwc), NeoDocs lets one order instant lab tests on their smartphone. The platform essentially transforms users’ smartphones into a mini lab – one can simply take the test, click a picture, and instantly receive the results on their phone. Currently, NeoDocs has tests covering panels including hydration, pH levels, sleep, energy, mood, skin, liver health, kidney health, ketones, UTI, immunity, etc.

Other investors that participated in the fund raise include Gemba Capital, Prophetic Ventures, Rohit MA (Founder, Cloudnine Hospitals), Ramakant Sharma (Founder, LivSpace), Abhishek Goyal (Founder, Tracxn), Bain & Co. partners Arpan Sheth and Prashant Sarin, Nipun Goyal (Founder, LikeMinds), Sumit Chhazed (Founder, Oto Capital) and Dr. Rohit Srivastava (HOD, Biosciences & Biomedical Engineering, IIT Bombay), among others.

Speaking on the fund raise, Nikunj Malpani, Co-founder and CEO, NeoDocs, said, “Testing is shifting to an at-home, instant and high frequency model. And this shift has been further catalysed by the pandemic. NeoDocs lets people take control of their health into their own hands, quite literally.”


Anurag Meena, Co-founder and COO, Neodocs, added, “Most common nutritional deficiencies that Indian adults grapple with are due to inadequate consumption of proteins, vitamin D, iron, vitamin B12 and folate. Majority of these people never get to not know about this.”

“The tech is now ready to track your biomarkers at home, using your smartphone” added Pratik Lodha, Co-founder and CTO, NeoDocs.

Commenting on the investment, Dr. Apoorva Ranjan Sharma, Co-founder and Managing Director – 9Unicorns, commented, “NeoDocs’s proprietary AI engine offers a great value proposition for both consumers and the healthcare industry at large. While the state-of-the-art, first-of-its-kind product caught our eye, it was the futuristic yet attainable vision of the founding team that clinched the deal for us. Their strategies are well aligned to address the need gaps in diagnostic testing market. We are delighted to support such a dynamic, disruptive startup like theirs and will provide 360-degree to their growth journey.”

Rohit MA, Founder - Cloudnine Hospitals, added, “Today, home sample collection is the fastest growing revenue channel in diagnostics, and is expected to further grow exponentially in the post-covid era. Anurag, Pratik and Nikunj are looking to disrupt the Indian diagnostics industry by bringing the entire lab into one’s smartphone, at a fraction of the cost. Excited to back them and their ambitious vision.”